William NewellCEO at Sutro Biopharma, Inc.
Mr. Newell has over 20 years of senior management experience in the biotechnology industry. He joined Sutro Biopharma, Inc. (NASDAQ: STRO) as CEO in January 2009. Previously, he served as the President of Aerovance, Inc., a venture-backed company developing clinical assets for respiratory diseases. Mr. Newell also was Chief Business Officer and Senior Vice President at publicly-traded QLT, Inc. and served in several senior management positions at public-traded Axys Pharmaceuticals, Inc. For the 16 years prior to joining Axys, Mr. Newell practiced corporate law in the San Francisco Bay Area. He is presently a member of the Board at SutroVax. Mr. Newell is also a Board member on BIO’s Emerging Companies Section, BIO’s Health Section Governing Board and a member of the Board and Chairman of the Board of the California Life Sciences Association.